Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.76379 | 62 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.79507 | 74 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.56691 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.5884 | 71 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.34205 | 70 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.4323 | 71 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.22119 | 68 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.4124 | 71 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.67636 | 73 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.5195 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.50417 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.03221 | 75 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.52165 | 72 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.42518 | 71 |